Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: cyclodextrin

July 6, 2022 Events

V International Summer School on Cyclodextrins

The 4-7 September 2022 in Ascea (Salerno, Italy) is the V International Summer School on Cyclodextrins, which welcomes graduate students,

Continue reading

April 27, 2022 Analysis

Cyclodextrins interfere in the ORAC method to measure antioxidant activity

                Oxygen Radical Absorbance Capacity (ORAC) is a water-based method commonly used to determine the antioxidant capacity of bioactive compounds

Continue reading

February 21, 2022 Drug delivery / Pharma applications

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug Niclosamide

Direct extrusion of hydroxypropyl beta-cyclodextrin (HP-β-CD)-based powder blends using the most innovative 3D printing technology, Direct Powder Extrusion (DPE), is

Continue reading

December 9, 2021 Non-pharma applications / Pharma applications

Barentz Acquires Gangwal in India

Barentz International, a leading global life science ingredients distributor announced an agreement to acquire a majority stake in the distribution

Continue reading

May 8, 2020 CD as API / CD derivatives / Pharma applications / Uncategorized

UC Berkeley, Excivion and CycloLab develop antiviral cyclodextrins against SARS-CoV-2

UC Berkeley, Excivion and Cyclolab announce a supplemental grant awarded to UC Berkeley by the National Institutes of Health to evaluate a wide

Continue reading

Recent Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • Small anticancer drug release by light
  • Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (199)
  • CD derivatives (251)
  • Cosmetics and toilettry (21)
  • Drug delivery (416)
  • E-ducation (54)
  • Environmental (76)
  • Events (157)
  • Food (120)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (13)
  • Non-pharma applications (209)
  • Other industrial use (58)
  • Pharma applications (677)
  • Supramolecular systems (25)
  • Uncategorized (41)

Top Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Lanosterol eye drops for cataract treatment
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • New book: Cyclodextrins - new Perspectives
  • Small anticancer drug release by light
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products
  • Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters
  • Published compilation of the list of approved cyclodextrin-containing drug products
  • Pilocarpine eye drops (Vuity)
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 521 other subscribers
 

Loading Comments...